search
Drug Topics
Trends
- 1AI Clinical Monitoring Tool Reported to Cut Trial Costs by Millions▼AI Clinical Monitoring Tool Saves Millions in Trial Costs
An AI-powered clinical monitoring tool is reported to have saved millions of dollars in clinical trial costs, according to coverage in The Scientist. The tool is said to streamline monitoring of trial sites, reducing manual oversight work and associated expenses. The report highlights growing interest in applying artificial intelligence to make drug development faster and cheaper, though detailed figures and trial specifics were not provided.
- 2Shocking Side Effects of Obesity Drugs Revealed●Shocking Side Effects of Obesity Drugs Finally Revealed (A Medicine Turned Poison...?) | Science ...
A science-focused explorer claims obesity medications may carry serious, previously underreported side effects, framing the situation as a medicine turned poison. The piece suggests people using or considering weight-loss drugs should pay closer attention to adverse reactions. No specific drug names, findings, or medical sources are given, so the scale of the alleged risks remains unclear, but the topic is drawing large attention amid the global boom in weight-loss injections.
- 3GLP-1 drugs, mental health and exercise in menopause examined▼GLP-1's and mental health; exercise and menopause
Public health coverage is drawing together two related topics: the possible mental health effects of GLP-1 weight-loss and diabetes drugs, and the role of exercise for women going through menopause. Listeners are weighing reported mood changes linked to GLP-1 medications against growing evidence that physical activity can ease menopause symptoms such as hot flashes, sleep problems and weight gain.
- 4Health roundup: salmonella outbreak, GLP-1 vision risks, testosterone●Wellness Wednesday: Cychlorphine, testosterone levels, GLP-1 and vision loss, jalapeño salmonella outbreak
A recurring health news segment covers four topics: cychlorphine, an emerging synthetic opioid; concerns over low testosterone levels; reports linking GLP-1 weight-loss drugs to vision loss; and a salmonella outbreak tied to jalapeños. The segment recaps what viewers need to know about the latest developments in each story, from drug safety warnings to a foodborne illness investigation affecting consumers.
- 5
Kiplinger has published a guide listing ten key facts about Medicare Part D prescription drug plans. The rundown covers what enrollees should understand when choosing or reviewing drug coverage, a topic of recurring interest to older Americans and those approaching eligibility. It comes as beneficiaries weigh plan options and costs under the federal prescription drug program.
- 6FAQ Released on Pharmacists' Understanding of mRNA Vaccine Technology▼FAQ: Pharmacist Understanding of mRNA Vaccine Technology
Drug Topics has published a FAQ addressing how well pharmacists understand mRNA vaccine technology. The piece answers common questions about the science behind mRNA vaccines and what pharmacists should know when advising patients. It reflects continued professional interest in keeping pharmacy staff up to date on vaccine technology and public communication.